1 – 80 of 80
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
2024) In Scandinavian Journal of Surgery(
- Contribution to journal › Article
-
Mark
Microbiome alterations in pancreatic cancer : new insights and potential clinical implications
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anoikis-related genes linked with patient outcome in pancreatic cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Neoadjuvant chemo(radio)therapy in upfront resectable pancreatic cancer–can we stratify patients better in the future?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article
-
Mark
Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy
(
- Contribution to journal › Article
-
Mark
Model-based screening for pancreatic cancer in Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer–the past, the present, and the future
(
- Contribution to journal › Scientific review
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas
(
- Contribution to journal › Article
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
-
Mark
Macropinocytosis : the Achilles’ heel of pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
(
- Contribution to journal › Article
-
Mark
Re-resection for incidentally detected gallbladder cancer : Weighing in on the options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma
(
- Contribution to journal › Article
-
Mark
Blood-based markers for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas–what’s beyond the horizon?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
(
- Contribution to journal › Article
-
Mark
Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome
(
- Contribution to journal › Article
- 2019
-
Mark
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Proteomic and genomic profiling of pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
(
- Contribution to journal › Article
-
Mark
The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer
(
- Contribution to journal › Scientific review
-
Mark
Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Early-onset pancreatic cancer : a population-based study using the SEER registry
(
- Contribution to journal › Article
-
Mark
Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Incidental metastases and lymphoma of the gallbladder–an analysis of ten rare cases identified from a large national database
(
- Contribution to journal › Article
-
Mark
The role of PEDF in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Centrosomal Abnormalities in Pancreatic Cancer : Molecular Mechanisms and Clinical Implications
(
- Contribution to journal › Scientific review
-
Mark
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm
(
- Contribution to journal › Article
-
Mark
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Targeting dendritic cells in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Primary lymph node ratio and hepatic resection for colorectal metastases
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment
(
- Contribution to journal › Scientific review
-
Mark
Thymidylate synthase : A predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment
(
- Contribution to journal › Article
-
Mark
Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
The prognostic role of cancer stem cell markers for long-term outcome after resection of colonic liver metastases
(
- Contribution to journal › Article
- 2017
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article
-
Mark
Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas
(
- Contribution to journal › Scientific review
-
Mark
Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer : a systematic review of safety and efficacy
(
- Contribution to journal › Scientific review
-
Mark
Pankreascancer kan metastasera tidigt : Tumörbiologi tycks viktigare än tumörstorlek
(
- Contribution to journal › Article
-
Mark
Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms : Relevant for decision making?
(
- Contribution to journal › Scientific review
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease : Results from a population-based gallstone surgery registry
(
- Contribution to journal › Article
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Pancreatic ductal adenocarcinoma : Is a cure possible?
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic cancer stroma : controversies and current insights
(
- Contribution to journal › Scientific review
-
Mark
Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Paradoxical role of hmgb1 in pancreatic cancer : Tumor suppressor or tumor promoter?
(
- Contribution to journal › Scientific review
-
Mark
Immune checkpoint therapy for pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic cancer : Yesterday, today and tomorrow
(
- Contribution to journal › Article
-
Mark
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
(
- Contribution to journal › Article
-
Mark
Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of histone related modifications of formaldehyde fixed paraffin embedded and fresh frozen pancreatic tumor xenografts using LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Impact by pancreatic stellate cells on epithelial-mesenchymal transition and pancreatic cancer cell invasion : Adding a third dimension in vitro
(
- Contribution to journal › Article
- 2015
-
Mark
Conditionally immortalized human pancreatic stellate cell lines demonstrate enhanced proliferation and migration in response to IGF-I.
(
- Contribution to journal › Article
-
Mark
SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer.
(
- Contribution to journal › Article
-
Mark
Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy-a potential novel tool for pancreatic cancer therapy?
(
- Contribution to journal › Scientific review
-
Mark
Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative study.
(
- Contribution to journal › Article
- 2014
-
Mark
The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.
(
- Contribution to journal › Scientific review
-
Mark
Analysis of MUC4 Expression in Human Pancreatic Cancer Xenografts in Immunodeficient Mice.
(
- Contribution to journal › Article
-
Mark
Apicidin Sensitizes Pancreatic Cancer Cells to Gemcitabine by Epigenetically Regulating MUC4 Expression.
(
- Contribution to journal › Article
- 2013
-
Mark
Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
(
- Contribution to journal › Article
-
Mark
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
(
- Contribution to journal › Article
-
Mark
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer - cost for overtreatment with gemcitabine.
(
- Contribution to journal › Article
- 2012
-
Mark
Solitary liver lesions of indeterminate malignancy - outcome following surgical resection.
(
- Contribution to journal › Article
-
Mark
Identification of serum biomarker signatures associated with pancreatic cancer
(
- Contribution to journal › Article